Window of Opportunity Study of DSP-0390 in Gliomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Window of Opportunity Study of DSP-0390 in Gliomas — Stella

Home/Glioma, Malignant/

View on ClinicalTrials.gov

Recruiting

Back to Glioma, Malignant trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Washington University School of Medicine, St Louis, Missouri

Key details

Phase

Very early testing

Sponsor

Washington University School of Medicine

Collaborators

Sumitomo Pharma America, Inc.

Enrollment target

~20 participants

Started

April 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years and older

Last updated February 2026